基于CRISPR/Cas9技术的IRF7缺乏的MDBK细胞用于增强IBRV复制
Guiyang Ge1, Dongli Li2, Qian Ling3
1College of Animal Science and Technology, Jilin Agricultural University, Changchun, China.
Frontiers in microbiology
|December 18, 2024
概括
研究人员开发了IRF7删除的MDBK细胞,以改善牛感染性鼻炎 (IBR) 疫苗生产. 这些修改后的细胞增强了牛类αherpesvirus-1 (BoAHV-1) 的复制,使得能够创建更高位数的疫苗.
科学领域:
- 兽医病毒学 兽医病毒学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 由牛αherpesvirus-1 (BoAHV-1) 引起的牛感染性鼻炎 (IBR) 是一种通过疫苗接种管理的重大牛病.
- 马丁-达比牛 (MDBK) 细胞对于IBR疫苗生产至关重要,但它们受到病毒复制的先天免疫基因抑制的影响.
研究的目的:
- 开发IRF7删除的MDBK细胞,以增强牛αherpesvirus-1 (BoAHV-1) 复制.
- 为了促进生产高位传染性牛鼻炎 (IBR) 疫苗.
主要方法:
- 使用CRISPR/Cas9技术,在MDBK细胞中敲除了IRF7基因.
- 病毒生长曲线,CCK-8检测,细胞检测和qPCR被用来评估病毒复制和基因表达.
主要成果:
- 在MDBK细胞中IRF7淘汰显著增加IBRV复制能力.
- 在IRF7淘汰赛细胞中观察到I型干扰素 (IFN-α和IFN-β) 表达的显著减少.
- 在IRF7-/- MDBK细胞系中,表现出增强的高位IBRV的产生.
结论:
- 对于高位IBRV生产,IRF7淘汰MDBK细胞系是有效的.
- 这一进展支持开发更有效的非活化或减弱IBR疫苗.
相关概念视频
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K


